Published in J Mol Biol on June 08, 2007
Binding of small-molecule ligands to proteins: "what you see" is not always "what you get". Structure (2009) 2.83
Computations of standard binding free energies with molecular dynamics simulations. J Phys Chem B (2009) 2.80
Alchemical free energy methods for drug discovery: progress and challenges. Curr Opin Struct Biol (2011) 2.31
Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir. PLoS Comput Biol (2011) 2.31
Predicting ligand binding affinity with alchemical free energy methods in a polar model binding site. J Mol Biol (2009) 1.90
Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. J Cheminform (2009) 1.85
Are Protein Force Fields Getting Better? A Systematic Benchmark on 524 Diverse NMR Measurements. J Chem Theory Comput (2012) 1.68
Computational fragment-based binding site identification by ligand competitive saturation. PLoS Comput Biol (2009) 1.61
Rescoring docking hit lists for model cavity sites: predictions and experimental testing. J Mol Biol (2008) 1.57
The Binding Energy Distribution Analysis Method (BEDAM) for the Estimation of Protein-Ligand Binding Affinities. J Chem Theory Comput (2010) 1.52
Prediction of protein-ligand binding affinity by free energy simulations: assumptions, pitfalls and expectations. J Comput Aided Mol Des (2010) 1.41
Predicting hydration free energies using all-atom molecular dynamics simulations and multiple starting conformations. J Comput Aided Mol Des (2010) 1.39
Free Energy Perturbation Hamiltonian Replica-Exchange Molecular Dynamics (FEP/H-REMD) for Absolute Ligand Binding Free Energy Calculations. J Chem Theory Comput (2010) 1.35
Entropy-enthalpy compensation: role and ramifications in biomolecular ligand recognition and design. Annu Rev Biophys (2013) 1.32
Structure-based systems biology for analyzing off-target binding. Curr Opin Struct Biol (2011) 1.25
The free energy landscape of small molecule unbinding. PLoS Comput Biol (2011) 1.25
Standard binding free energies from computer simulations: What is the best strategy? J Chem Theory Comput (2013) 1.24
Druggability Assessment of Allosteric Proteins by Dynamics Simulations in the Presence of Probe Molecules. J Chem Theory Comput (2012) 1.18
Limits of Free Energy Computation for Protein-Ligand Interactions. J Chem Theory Comput (2010) 1.18
Recent theoretical and computational advances for modeling protein-ligand binding affinities. Adv Protein Chem Struct Biol (2011) 1.15
Molecular binding: Under water's influence. Nat Chem (2010) 1.13
Statistical mechanics and molecular dynamics in evaluating thermodynamic properties of biomolecular recognition. Q Rev Biophys (2011) 1.12
Perspective: Alchemical free energy calculations for drug discovery. J Chem Phys (2012) 1.10
Alchemical prediction of hydration free energies for SAMPL. J Comput Aided Mol Des (2011) 1.07
DOCK 6: Impact of new features and current docking performance. J Comput Chem (2015) 1.07
Let's get honest about sampling. J Comput Aided Mol Des (2011) 1.07
Blind prediction of charged ligand binding affinities in a model binding site. J Mol Biol (2013) 1.05
A machine learning-based method to improve docking scoring functions and its application to drug repurposing. J Chem Inf Model (2011) 1.03
Design of protein-ligand binding based on the molecular-mechanics energy model. J Mol Biol (2008) 1.01
Computational investigation of glycosylation effects on a family 1 carbohydrate-binding module. J Biol Chem (2011) 1.00
Classical electrostatics for biomolecular simulations. Chem Rev (2013) 1.00
Conformational Transitions and Convergence of Absolute Binding Free Energy Calculations. J Chem Theory Comput (2012) 0.99
AMMOS: Automated Molecular Mechanics Optimization tool for in silico Screening. BMC Bioinformatics (2008) 0.99
Small-molecule ligand docking into comparative models with Rosetta. Nat Protoc (2013) 0.96
Ligand binding to the voltage-gated Kv1.5 potassium channel in the open state--docking and computer simulations of a homology model. Biophys J (2007) 0.95
Lead optimization mapper: automating free energy calculations for lead optimization. J Comput Aided Mol Des (2013) 0.94
Multiscale Free Energy Simulations: An Efficient Method for Connecting Classical MD Simulations to QM or QM/MM Free Energies Using Non-Boltzmann Bennett Reweighting Schemes. J Chem Theory Comput (2014) 0.91
Docking Screens for Novel Ligands Conferring New Biology. J Med Chem (2016) 0.90
Elucidating the energetics of entropically driven protein-ligand association: calculations of absolute binding free energy and entropy. J Phys Chem B (2011) 0.88
Identifying ligand binding sites and poses using GPU-accelerated Hamiltonian replica exchange molecular dynamics. J Comput Aided Mol Des (2013) 0.87
Advances in free-energy-based simulations of protein folding and ligand binding. Curr Opin Struct Biol (2016) 0.87
Accounting for ligand conformational restriction in calculations of protein-ligand binding affinities. Biophys J (2010) 0.87
Absolute free energy of binding of avidin/biotin, revisited. J Phys Chem B (2012) 0.87
Bringing Clarity to the Prediction of Protein-Ligand Binding Free Energies via "Blurring" J Chem Theory Comput (2014) 0.86
Improved Binding Free Energy Predictions from Single-Reference Thermodynamic Integration Augmented with Hamiltonian Replica Exchange. J Chem Theory Comput (2011) 0.86
Application of a polarizable force field to calculations of relative protein-ligand binding affinities. Proc Natl Acad Sci U S A (2008) 0.85
Computing Relative Free Energies of Solvation using Single Reference Thermodynamic Integration Augmented with Hamiltonian Replica Exchange. J Chem Theory Comput (2010) 0.85
QM/MM refinement and analysis of protein bound retinoic acid. J Comput Chem (2011) 0.85
Separated topologies--a method for relative binding free energy calculations using orientational restraints. J Chem Phys (2013) 0.85
Predicting binding affinities of host-guest systems in the SAMPL3 blind challenge: the performance of relative free energy calculations. J Comput Aided Mol Des (2011) 0.85
Effects of Biomolecular Flexibility on Alchemical Calculations of Absolute Binding Free Energies. J Chem Theory Comput (2011) 0.85
The errors of our ways: taking account of error in computer-aided drug design to build confidence intervals for our next 25 years. J Comput Aided Mol Des (2012) 0.83
Calculating the sensitivity and robustness of binding free energy calculations to force field parameters. J Chem Theory Comput (2013) 0.83
Toward a molecular understanding of the interaction of dual specificity phosphatases with substrates: insights from structure-based modeling and high throughput screening. Curr Med Chem (2008) 0.83
Biomolecular Force Field Parameterization via Atoms-in-Molecule Electron Density Partitioning. J Chem Theory Comput (2016) 0.83
Enantiomeric discrimination of chiral organic salts by chiral aza-15-crown-5 ether with C 1 symmetry: experimental and theoretical approaches. J Mol Model (2015) 0.82
Implementation of the Hungarian algorithm to account for ligand symmetry and similarity in structure-based design. J Chem Inf Model (2014) 0.82
Using free energy of binding calculations to improve the accuracy of virtual screening predictions. J Chem Inf Model (2011) 0.82
Accurate calculation of mutational effects on the thermodynamics of inhibitor binding to p38α MAP kinase: a combined computational and experimental study. J Chem Theory Comput (2013) 0.82
New method for calculating the absolute free energy of binding: the effect of a mobile loop on the avidin/biotin complex. J Phys Chem B (2010) 0.81
Accurate calculation of the absolute free energy of binding for drug molecules. Chem Sci (2015) 0.80
Insights from free-energy calculations: protein conformational equilibrium, driving forces, and ligand-binding modes. Biophys J (2012) 0.80
Computation of relative binding free energy for an inhibitor and its analogs binding with Erk kinase using thermodynamic integration MD simulation. J Comput Aided Mol Des (2012) 0.80
Biophysical limits of protein-ligand binding. J Chem Inf Model (2012) 0.79
Calculation of the Absolute Free Energy of Binding and Related Entropies with the HSMD-TI Method: The FKBP12-L8 Complex. J Chem Theory Comput (2011) 0.79
Protein-Ligand Electrostatic Binding Free Energies from Explicit and Implicit Solvation. J Chem Theory Comput (2015) 0.79
Insights into Ligand-Protein Binding from Local Mechanical Response. J Chem Theory Comput (2011) 0.78
Path-integral method for predicting relative binding affinities of protein-ligand complexes. J Am Chem Soc (2009) 0.78
Site Identification by Ligand Competitive Saturation (SILCS) simulations for fragment-based drug design. Methods Mol Biol (2015) 0.78
Free energy calculations offer insights into the influence of receptor flexibility on ligand-receptor binding affinities. J Comput Aided Mol Des (2011) 0.78
Predicting Binding Free Energies. Annu Rev Biophys (2017) 0.78
Predictions of Ligand Selectivity from Absolute Binding Free Energy Calculations. J Am Chem Soc (2017) 0.77
Multiscale Monte Carlo Sampling of Protein Sidechains: Application to Binding Pocket Flexibility. J Chem Theory Comput (2008) 0.77
Using docking and alchemical free energy approach to determine the binding mechanism of eEF2K inhibitors and prioritizing the compound synthesis. Front Mol Biosci (2015) 0.77
Sensitivity in Binding Free Energies Due to Protein Reorganization. J Chem Theory Comput (2016) 0.76
Absolute binding free energies for octa-acids and guests in SAMPL5 : Evaluating binding free energies for octa-acid and guest complexes in the SAMPL5 blind challenge. J Comput Aided Mol Des (2016) 0.76
Quantifying water-mediated protein-ligand interactions in a glutamate receptor: a DFT study. J Phys Chem B (2011) 0.76
The measured and calculated affinity of methyl- and methoxy-substituted benzoquinones for the Q(A) site of bacterial reaction centers. Proteins (2010) 0.76
Optimal allosteric stabilization sites using contact stabilization analysis. J Comput Chem (2016) 0.75
Correlating protein hot spot surface analysis using ProBiS with simulated free energies of protein-protein interfacial residues. J Chem Inf Model (2012) 0.75
Absolute Binding Free Energies between T4 Lysozyme and 141 Small Molecules: Calculations Based on Multiple Rigid Receptor Configurations. J Chem Theory Comput (2017) 0.75
Docking-undocking combination applied to the D3R Grand Challenge 2015. J Comput Aided Mol Des (2016) 0.75
Dependency of ligand free energy landscapes on charge parameters and solvent models. J Comput Aided Mol Des (2010) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
GROMACS: fast, flexible, and free. J Comput Chem (2005) 27.22
Development and testing of a general amber force field. J Comput Chem (2004) 23.29
Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res (2000) 10.78
Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model (2006) 7.93
The statistical-thermodynamic basis for computation of binding affinities: a critical review. Biophys J (1997) 7.64
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J Comput Chem (2002) 6.67
Response of a protein structure to cavity-creating mutations and its relation to the hydrophobic effect. Science (1992) 6.51
Principles of docking: An overview of search algorithms and a guide to scoring functions. Proteins (2002) 5.79
Exploring the helix-coil transition via all-atom equilibrium ensemble simulations. Biophys J (2005) 4.26
Calculation of absolute protein-ligand binding free energy from computer simulations. Proc Natl Acad Sci U S A (2005) 3.21
On the value of c: can low affinity systems be studied by isothermal titration calorimetry? J Am Chem Soc (2003) 3.06
A model binding site for testing scoring functions in molecular docking. J Mol Biol (2002) 2.94
Absolute binding free energy calculations using molecular dynamics simulations with restraining potentials. Biophys J (2006) 2.88
Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences. J Mol Biol (1993) 2.50
Comparison of efficiency and bias of free energies computed by exponential averaging, the Bennett acceptance ratio, and thermodynamic integration. J Chem Phys (2005) 2.31
Comparison of charge models for fixed-charge force fields: small-molecule hydration free energies in explicit solvent. J Phys Chem B (2007) 2.31
Thermodynamic stability of water molecules in the bacteriorhodopsin proton channel: a molecular dynamics free energy perturbation study. Biophys J (1996) 2.30
Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity. Biochemistry (1995) 2.10
On the use of orientational restraints and symmetry corrections in alchemical free energy calculations. J Chem Phys (2006) 2.10
Second-site revertants of an inactive T4 lysozyme mutant restore activity by restructuring the active site cleft. Biochemistry (1991) 2.03
Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models. J Med Chem (2000) 1.92
Direct calculation of the binding free energies of FKBP ligands. J Chem Phys (2005) 1.88
On the importance of atomic fluctuations, protein flexibility, and solvent in ion permeation. J Gen Physiol (2004) 1.88
Energetic origins of specificity of ligand binding in an interior nonpolar cavity of T4 lysozyme. Biochemistry (1995) 1.75
Testing a flexible-receptor docking algorithm in a model binding site. J Mol Biol (2004) 1.73
The Confine-and-Release Method: Obtaining Correct Binding Free Energies in the Presence of Protein Conformational Change. J Chem Theory Comput (2007) 1.73
Ligand solvation in molecular docking. Proteins (1999) 1.65
Calculation of absolute protein-ligand binding affinity using path and endpoint approaches. Biophys J (2005) 1.65
Accurate and efficient corrections for missing dispersion interactions in molecular simulations. J Phys Chem B (2007) 1.49
Decoys for docking. J Med Chem (2005) 1.43
Evaluating the molecular mechanics poisson-boltzmann surface area free energy method using a congeneric series of ligands to p38 MAP kinase. J Med Chem (2005) 1.37
Molecular mechanics methods for predicting protein-ligand binding. Phys Chem Chem Phys (2006) 1.34
A new ultrasensitive scanning calorimeter. Anal Biochem (1997) 1.33
Modeling protein-small molecule interactions: structure and thermodynamics of noble gases binding in a cavity in mutant phage T4 lysozyme L99A. J Mol Biol (2000) 1.18
Potentials of mean force for acetylcholine unbinding from the alpha7 nicotinic acetylcholine receptor ligand-binding domain. J Am Chem Soc (2006) 1.15
A multistep approach to structure-based drug design: studying ligand binding at the human neutrophil elastase. J Med Chem (2006) 1.05
Enhancing the accuracy, the efficiency and the scope of free energy simulations. Curr Opin Struct Biol (2005) 1.02
Computational study of ground-state chiral induction in small peptides: comparison of the relative stability of selected amino acid dimers and oligomers in homochiral and heterochiral combinations. J Comput Chem (2006) 0.96
Calculation of the redox potential of the protein azurin and some mutants. Chembiochem (2005) 0.93
ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model (2005) 16.75
Predicting new molecular targets for known drugs. Nature (2009) 9.71
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature (2012) 7.01
Relating protein pharmacology by ligand chemistry. Nat Biotechnol (2007) 6.61
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem (2002) 5.67
Benchmarking sets for molecular docking. J Med Chem (2006) 5.57
Automatic discovery of metastable states for the construction of Markov models of macromolecular conformational dynamics. J Chem Phys (2007) 4.52
High-throughput assays for promiscuous inhibitors. Nat Chem Biol (2005) 4.32
A specific mechanism of nonspecific inhibition. J Med Chem (2003) 3.93
Large-scale prediction and testing of drug activity on side-effect targets. Nature (2012) 3.88
Statistically optimal analysis of samples from multiple equilibrium states. J Chem Phys (2008) 3.87
Prediction of protein-ligand interactions. Docking and scoring: successes and gaps. J Med Chem (2006) 3.85
Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. J Mol Biol (2002) 3.71
Structure-based activity prediction for an enzyme of unknown function. Nature (2007) 3.65
Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem (2003) 3.44
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proc Natl Acad Sci U S A (2012) 3.22
Current status of the AMOEBA polarizable force field. J Phys Chem B (2010) 3.06
Small-molecule aggregates inhibit amyloid polymerization. Nat Chem Biol (2008) 2.98
A high-throughput screen for aggregation-based inhibition in a large compound library. J Med Chem (2007) 2.97
A model binding site for testing scoring functions in molecular docking. J Mol Biol (2002) 2.94
Using quaternions to calculate RMSD. J Comput Chem (2004) 2.93
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem (2012) 2.86
Binding of small-molecule ligands to proteins: "what you see" is not always "what you get". Structure (2009) 2.83
A detergent-based assay for the detection of promiscuous inhibitors. Nat Protoc (2006) 2.58
Small molecule hydration free energies in explicit solvent: An extensive test of fixed-charge atomistic simulations. J Chem Theory Comput (2009) 2.53
Structure-based discovery of beta2-adrenergic receptor ligands. Proc Natl Acad Sci U S A (2009) 2.48
Markov models of molecular kinetics: generation and validation. J Chem Phys (2011) 2.41
Comparison of charge models for fixed-charge force fields: small-molecule hydration free energies in explicit solvent. J Phys Chem B (2007) 2.31
Predicting small-molecule solvation free energies: an informal blind test for computational chemistry. J Med Chem (2008) 2.27
Deconstructing fragment-based inhibitor discovery. Nat Chem Biol (2006) 2.19
Automated docking screens: a feasibility study. J Med Chem (2009) 2.14
Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J Med Chem (2002) 2.10
Ligand discovery from a dopamine D3 receptor homology model and crystal structure. Nat Chem Biol (2011) 2.10
On the use of orientational restraints and symmetry corrections in alchemical free energy calculations. J Chem Phys (2006) 2.10
OpenMM 4: A Reusable, Extensible, Hardware Independent Library for High Performance Molecular Simulation. J Chem Theory Comput (2012) 2.07
Assessment of protein structure refinement in CASP9. Proteins (2011) 2.06
A kinematic view of loop closure. J Comput Chem (2004) 2.03
Quantifying the relationships among drug classes. J Chem Inf Model (2008) 1.92
Structural bases of stability-function tradeoffs in enzymes. J Mol Biol (2002) 1.91
Kinase inhibitors: not just for kinases anymore. J Med Chem (2003) 1.90
Predicting ligand binding affinity with alchemical free energy methods in a polar model binding site. J Mol Biol (2009) 1.90
The Enzyme Function Initiative. Biochemistry (2011) 1.87
How ions affect the structure of water. J Am Chem Soc (2002) 1.84
Predicting substrates by docking high-energy intermediates to enzyme structures. J Am Chem Soc (2006) 1.81
An ultrahigh resolution structure of TEM-1 beta-lactamase suggests a role for Glu166 as the general base in acylation. J Am Chem Soc (2002) 1.81
Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase. J Med Chem (2008) 1.81
Hierarchical docking of databases of multiple ligand conformations. Curr Top Med Chem (2005) 1.79
Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors. J Am Chem Soc (2008) 1.74
Testing a flexible-receptor docking algorithm in a model binding site. J Mol Biol (2004) 1.73
The Confine-and-Release Method: Obtaining Correct Binding Free Energies in the Presence of Protein Conformational Change. J Chem Theory Comput (2007) 1.73
Protein folding by zipping and assembly. Proc Natl Acad Sci U S A (2007) 1.72
Structure-based discovery of A2A adenosine receptor ligands. J Med Chem (2010) 1.71
Information decay in molecular docking screens against holo, apo, and modeled conformations of enzymes. J Med Chem (2003) 1.70
Structure-based discovery of a novel, noncovalent inhibitor of AmpC beta-lactamase. Structure (2002) 1.70
The protein folding problem: when will it be solved? Curr Opin Struct Biol (2007) 1.70
Promiscuous aggregate-based inhibitors promote enzyme unfolding. J Med Chem (2009) 1.68
Rapid context-dependent ligand desolvation in molecular docking. J Chem Inf Model (2010) 1.66
Nonuniversal power law scaling in the probability distribution of scientific citations. Proc Natl Acad Sci U S A (2010) 1.66
Quantifying biogenic bias in screening libraries. Nat Chem Biol (2009) 1.66
A pharmacological organization of G protein-coupled receptors. Nat Methods (2013) 1.65
Protein-protein docking with multiple residue conformations and residue substitutions. Protein Sci (2002) 1.61
Molecular docking and ligand specificity in fragment-based inhibitor discovery. Nat Chem Biol (2009) 1.60
Rescoring docking hit lists for model cavity sites: predictions and experimental testing. J Mol Biol (2008) 1.57
Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart. Sci Transl Med (2013) 1.55
Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors. J Med Chem (2010) 1.54
Structural milestones in the reaction pathway of an amide hydrolase: substrate, acyl, and product complexes of cephalothin with AmpC beta-lactamase. Structure (2002) 1.54
Assessment of the protein-structure refinement category in CASP8. Proteins (2009) 1.53
Ligand-selective inhibition of the interaction of steroid receptor coactivators and estrogen receptor isoforms. Chem Biol (2004) 1.53
The ribosome modulates nascent protein folding. Science (2011) 1.51
Accurate and efficient corrections for missing dispersion interactions in molecular simulations. J Phys Chem B (2007) 1.49
Soft docking and multiple receptor conformations in virtual screening. J Med Chem (2004) 1.47
Treating entropy and conformational changes in implicit solvent simulations of small molecules. J Phys Chem B (2008) 1.47
Docking and chemoinformatic screens for new ligands and targets. Curr Opin Biotechnol (2009) 1.47
In silico molecular comparisons of C. elegans and mammalian pharmacology identify distinct targets that regulate feeding. PLoS Biol (2013) 1.47
Functional annotation and three-dimensional structure of Dr0930 from Deinococcus radiodurans, a close relative of phosphotriesterase in the amidohydrolase superfamily. Biochemistry (2009) 1.47
Virtual screening against metalloenzymes for inhibitors and substrates. Biochemistry (2005) 1.46
Charge asymmetries in hydration of polar solutes. J Phys Chem B (2008) 1.45
Structure-based approach for binding site identification on AmpC beta-lactamase. J Med Chem (2002) 1.45
Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. J Med Chem (2010) 1.45
Decoys for docking. J Med Chem (2005) 1.43
Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough. J Biol Chem (2003) 1.43
Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures. J Med Chem (2006) 1.42
Nanomolar inhibitors of AmpC beta-lactamase. J Am Chem Soc (2003) 1.41
Structural and spectroscopic studies of peptoid oligomers with alpha-chiral aliphatic side chains. J Am Chem Soc (2003) 1.39
Structural basis for imipenem inhibition of class C beta-lactamases. Antimicrob Agents Chemother (2002) 1.39
Stability and equilibria of promiscuous aggregates in high protein milieus. Mol Biosyst (2007) 1.38
A test on peptide stability of AMBER force fields with implicit solvation. J Phys Chem B (2008) 1.38
Chemical informatics and target identification in a zebrafish phenotypic screen. Nat Chem Biol (2011) 1.37
Identifying mechanism-of-action targets for drugs and probes. Proc Natl Acad Sci U S A (2012) 1.36
Molecular docking screens using comparative models of proteins. J Chem Inf Model (2009) 1.36
Ion pairing in molecular simulations of aqueous alkali halide solutions. J Phys Chem B (2009) 1.35
Structural consequences of the inhibitor-resistant Ser130Gly substitution in TEM beta-lactamase. Biochemistry (2005) 1.32
Discovery of small molecule inhibitors of the interaction of the thyroid hormone receptor with transcriptional coregulators. J Biol Chem (2005) 1.32